Summary
Global Market Directs pharmaceuticals report, Alchemia Limited - Product Pipeline Review - 2012 provides data on the Alchemia Limiteds research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
This report is built using data and information sourced from Global Markets Directs proprietary databases, Alchemia Limiteds corporate website, SEC filings, investor presentations and featured press releases, both from Alchemia Limited and industry-specific third party sources, put together by Global Markets Directs team.
Scope
- Alchemia Limited - Brief Alchemia Limited overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Alchemia Limited human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
Table of contents:
List of Tables 5
List of Figures 6
Alchemia Limited Snapshot 7
Alchemia Limited Overview 7
Key Information 7
Key Facts 7
Alchemia Limited Research and Development Overview 8
Key Therapeutic Areas 8
Alchemia Limited Pipeline Review 11
Pipeline Products by Stage of Development 11
Pipeline Products Monotherapy 12
Pipeline Products Combination Treatment Modalities 13
Alchemia Limited Pipeline Products Glance 14
Alchemia Limited Late Stage Pipeline 14
Phase III Products/Combination Treatment Modalities 14
Alchemia Limited Clinical Stage Pipeline Products 15
Phase II
Products/Combination Treatment Modalities 15
Alchemia Limited Early Stage Pipeline Products 16
Pre-Clinical Products/Combination Treatment Modalities 16
Discovery Products/Combination Treatment Modalities 17
Alchemia Limited Drug Profiles 18
Antibiotic Program 18
Product Description 18
Mechanism of Action 18
RD Progress 18
COPD VAST Program 19
Product Description 19
Mechanism of Action 19
RD Progress 19
FOLF(HA)Iri 20
Product Description 20
Mechanism of Action 20
RD Progress 20
HA-Irinotecan 22
Product Description 22
Mechanism of Action 22
RD Progress 22
HyACT-Carboplatin 24
Product Description 24
Mechanism of Action 24
RD Progress 24
HyACT-Gemcitabine 25
Product Description 25
Mechanism of Action 25
RD Progress 25
HyACT-Vinorelbine Tartrate 26
Product Description 26
Mechanism of Action 26
List of Figures
List of Tables are also include.
For more related Reports Plz follow The link:
Product Pipeline Review 2012
http://www.aarkstore.com/search/viewresults.asp?search=Product Pipeline Review 2012PubId=pagenum=1
Achillion Pharmaceuticals, Inc. Product Pipeline Review 2012
Addex Therapeutics Product Pipeline Review 2012
Adherex Technologies Inc. Product Pipeline Review 2012
Alchemia Limited Product Pipeline Review 2012
ALK-Abello A/S Product Pipeline Review 2012
Onchocerciasis (River Blindness) Pipeline Review, H1 2012
Seborrhea Pipeline Review, H1 2012
Cerebral Palsy Pipeline Review, H1 2012
Hemolytic Disease In Newborns Pipeline Review, H1 2012
Panic Disorders Pipeline Review, H1 2012
4SC AG Product Pipeline Review 2012
Search More Reports Related to This Category :
Pharmaceuticals and Healthcare
http://www.aarkstore.com/search/viewresults.asp?search=Pharmaceuticals and HealthcarePubId=pagenum=1
For More details Plz do contact :
Aarkstore Enterprise
Lavanya
Phone:08149852585
Email: enquiry@aarkstore.com
